Bioprinting technology has attracted significant attention in the field of tissue engineering, enabling the precise placement of cells, biomaterials, and biomolecules to construct 3D tissue and organ structures. This review explores the feasibility of bioprinting functional organs by assessing current advancements in the field. A poll conducted among people from diverse backgrounds reveals common optimism regarding the future of organ bioprinting and its role in medicine and other fields. The article is conceptualized from a student‐to‐student perspective to provide a brief overview of key aspects of bioprinting, including bioinks, crosslinking techniques, bioprinting methods, and the maturation process required to develop functional tissues. Furthermore, it highlights recent progress in printing specific tissues as models for studying healthy and diseased tissues as well as implantable grafts. While there are still significant challenges that require the integration of technologies from engineering, biomaterials science, cell biology, physics, and medicine, ongoing research continues to address these complexities. The possibilities of bioprinting tissues and organs go beyond minimizing dependence on animal testing and advancing drug discovery; indeed, this approach also opens the door to accessible personalized medicine and presents a viable solution to the worldwide organ donor shortage.
Tomographic volumetric additive manufacturing (tVAM) enables rapid 3D printing of constructs with intricate, freestanding geometries. Besides demonstrating very promising applications in tissue engineering and biofabrication, a limitation of the technology has been the relatively high material consumption and limited maximal model size due to optical and technical constraints. Here we demonstrate the fabrication and use of highly modular hollow structures created with tVAM to produce large scale tubular systems that allow the formation of complex, hollow networks beyond the build space of commercial tVAM devices. In many cases, it can reduce the overall dead volume used for printing by more than 50% compared to printing the whole structure at once. As proof of concept, we made a channel system recapitulating the physiological complexity of human vasculature in vitro. The system was tested with liquid flow dynamic and stent placement into stenosed segments to show that leak tight models could be created. Further, by using gelatin methacryloyl, a large-scale system out of seven single units could be created and effectively endothelialized, showing the potential of the approach for fabrication of physiological stent placement phantoms or vascular tissue models. Table of content figure:
Insufficient vascularization remains a major limitation in tissue engineering, restricting the survival and maturation of larger bioengineered constructs. While candidate hydrogels are commonly characterized with regard to physicochemical properties, gelation behavior, mechanical performance, and cytocompatibility, simple functional assays that assess their capacity to support vascular sprouting are less frequently integrated into early-stage biomaterial evaluation. Here, we investigated the established ex vivo aortic ring assay (ARA) as an exploratory functional approach for the initial comparison of selected hydrogel formulations. Murine aortic rings were embedded in collagen I (Col I), alginate (Alg), or gelatin methacryloyl (GelMA) and cultured under control conditions or with vascular endothelial growth factor A (VEGF-A) stimulation. These hydrogels were intentionally selected as a proof-of-concept panel of representative, non-equivalent material classes with distinct expected cell-interactive properties. After five days, Col I supported robust capillary-like outgrowth that was further enhanced by VEGF-A, whereas the tested GelMA formulation supported only limited cellular migration and the tested unmodified Alg formulation showed no detectable sprouting under the conditions examined. Cluster of differentiation 31 (CD31) immunostaining supported the presence of an endothelial component within the Col I-supported sprouting structures. These findings demonstrate that the ARA can detect pronounced formulation-dependent differences among the specific hydrogels tested using straightforward morphological and immunostaining readouts. Within the scope of the formulations tested, these findings support the ARA as a complementary functional readout alongside conventional biomaterial characterization before more complex tissue engineering or biofabrication studies are performed.